These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14747301)

  • 1. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients.
    Sasahara M; Nishi M; Kawashima H; Ueda K; Sakagashira S; Furuta H; Matsumoto E; Hanabusa T; Sasaki H; Nanjo K
    Diabetes; 2004 Feb; 53(2):482-5. PubMed ID: 14747301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common polymorphism of uncoupling protein 2 gene is associated with hypertension.
    Ji Q; Ikegami H; Fujisawa T; Kawabata Y; Ono M; Nishino M; Ohishi M; Katsuya T; Rakugi H; Ogihara T
    J Hypertens; 2004 Jan; 22(1):97-102. PubMed ID: 15106800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
    Sesti G; Cardellini M; Marini MA; Frontoni S; D'Adamo M; Del Guerra S; Lauro D; De Nicolais P; Sbraccia P; Del Prato S; Gambardella S; Federici M; Marchetti P; Lauro R
    Diabetes; 2003 May; 52(5):1280-3. PubMed ID: 12716765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
    Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
    Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
    Bulotta A; Ludovico O; Coco A; Di Paola R; Quattrone A; Carella M; Pellegrini F; Prudente S; Trischitta V
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1176-80. PubMed ID: 15562023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients.
    Yamasaki H; Sasaki H; Ogawa K; Shono T; Tamura S; Doi A; Sasahara M; Kawashima H; Nakao T; Furuta H; Nishi M; Nanjo K
    Diabetes Care; 2006 Apr; 29(4):888-94. PubMed ID: 16567833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and rapid detection of uncoupling protein-2 - 866G/A polymorphism by mutagenically separated polymerase chain reaction.
    Zhang B; Tanaka H; Saku K
    Clin Chim Acta; 2004 Jun; 344(1-2):205-10. PubMed ID: 15149891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion.
    Wang H; Chu WS; Lu T; Hasstedt SJ; Kern PA; Elbein SC
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E1-7. PubMed ID: 12915397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of functional UCP2 -866G/A and Ala55Val polymorphisms and type 2 diabetes in the Chinese population based on a case-control study and a meta-analysis.
    Qin LJ; Wen J; Qu YL; Huang QY
    Genet Mol Res; 2013 Sep; 12(3):3324-34. PubMed ID: 24065674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes.
    Reis AF; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Mol Genet Metab; 2004 Aug; 82(4):339-44. PubMed ID: 15308133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians.
    Kovacs P; Ma L; Hanson RL; Franks P; Stumvoll M; Bogardus C; Baier LJ
    Diabetologia; 2005 Nov; 48(11):2292-5. PubMed ID: 16167150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The common -866G/A polymorphism of the UCP2 gene in healthy Iranians compared with world populations.
    Akrami SM; Heidari J; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Hum Biol; 2007 Feb; 79(1):103-10. PubMed ID: 17985659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
    Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
    Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.
    Zhang CY; Baffy G; Perret P; Krauss S; Peroni O; Grujic D; Hagen T; Vidal-Puig AJ; Boss O; Kim YB; Zheng XX; Wheeler MB; Shulman GI; Chan CB; Lowell BB
    Cell; 2001 Jun; 105(6):745-55. PubMed ID: 11440717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women.
    Oberkofler H; Iglseder B; Klein K; Unger J; Haltmayer M; Krempler F; Paulweber B; Patsch W
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):604-10. PubMed ID: 15604415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.
    Cheurfa N; Dubois-Laforgue D; Ferrarezi DA; Reis AF; Brenner GM; Bouché C; Le Feuvre C; Fumeron F; Timsit J; Marre M; Velho G
    Diabetes; 2008 Apr; 57(4):1063-8. PubMed ID: 18192542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.
    Liu L; Liu J; Gao Y; Yu X; Xu G; Huang Y
    Br J Pharmacol; 2014 Jul; 171(13):3246-54. PubMed ID: 24588674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.